Skip to main content
Equibles
CME logo

CME · Cme Group Inc. · Metrics

Track CME — free

Use CME with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CME.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$305.71 -0.27 (-0.09%) At close · Oct 23
S&P 500 member Russell 1000 member Rebalance outlook locked
Customer concentration — top 2 customers 25% of revenue

2 customers — 25% of revenue (first six months of 2026)

“The two largest resellers of our market data represented approximately 25% of our market data and information services revenue in the first six months of 2026.”

One customer — 10% of revenue (first six months of 2026)

“One individual firm represented at least 10% of our clearing and transaction fees in the first six months of 2026.”
View the 10-Q filed Jul 24, 2026
Market Cap
$109.42B
Shares
357.93M
Volume · Oct 23 2.18M Avg daily vol (3M) 1.97M

CME metrics

102 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$305.71
Market cap
$109.42B

Price action

20 metrics
Price change (1W)
+4.0%
Price change (30D)
+12.9%
Price change (3M)
+19.7%
Price change (6M)
+7.2%
Price change (YTD)
+11.9%
Price change (1Y)
+13.7%
Trailing year
Price change (5Y)
+40.3%
52-week high
$326.46
52-week low
$218.58
Change from 52-week high
-6.4%
Change from 52-week low
+39.9%
Annualized volatility
24.7%
Annualized volatility (3M)
21.2%
Beta
-0.3
RSI (14D)
77.8
Price vs SMA 50
+10.2%
Price vs SMA 200
+9.4%
Avg volume (3M)
1.97M
Relative volume
1.1
Average dollar volume
$541.05M

Company

3 metrics
Sector
Financial Services
Industry
Financial Data & Stock Exchanges
Shares outstanding
357.93M

Valuation

12 metrics
P / E (TTM)
25.1
Trailing earnings · reciprocal yield 4.0%
PEG ratio
1.6
EV / revenue
15.0×
reciprocal yield 6.6%
EV / EBITDA
39.2×
reciprocal yield 2.5%
EV / EBIT
22.9×
reciprocal yield 4.4%
P / sales
15.7×
reciprocal yield 6.4%
P / book
4.1
reciprocal yield 24.3%
FCF yield
4.0%
TTM · current market cap
Buyback yield
—
P / FCF
25.3
reciprocal yield 4.0%
P / operating cash flow
24.7
reciprocal yield 4.0%
Earnings yield
4.0%

Historical valuation

8 metrics
P / E historical average (3Y)
25.0×
reciprocal yield 4.0%
P / E historical average (5Y)
25.7×
reciprocal yield 3.9%
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
3.7%
Trailing 12 months
Payout ratio
92.5%
Shareholder yield
3.7%
Dividend / share (TTM)
$11.30
Dividend growth YoY
+5.6%
Dividend growth streak
0
Last ex-dividend
2026-09-09

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-10-21

Profitability

9 metrics
Gross margin
—
Operating margin
65.7%
Trailing 12 months
Net margin
63.3%
Gross profit (TTM)
—
Operating profit (TTM)
$4.58B
Net income (TTM)
$4.42B
Trailing 12 months
Diluted EPS (TTM)
$12.19
FCF margin
62.1%
Effective tax rate
23.5%

Per share

11 metrics
Revenue per diluted share (TTM)
$19.32
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
$12.68
EBITDA per diluted share (TTM)
$7.67
Net income per diluted share (TTM)
$12.24
Operating cash flow per diluted share (TTM)
$12.27
Free cash flow per diluted share (TTM)
$12.01
Capital expenditures per diluted share (TTM)
$0.26
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
$0.28
Book value per share
—

Growth

11 metrics
Revenue growth YoY
+13.0%
Year over year
Net income growth YoY
+14.2%
Revenue (TTM)
$6.97B
Trailing 12 months
EPS growth YoY
+16.1%
Shares change YoY
-0.5%
Year over year · fewer shares
Revenue CAGR (3Y)
+9.1%
Revenue CAGR (5Y)
+6.0%
EPS CAGR (3Y)
+14.7%
EPS CAGR (5Y)
+13.7%
FCF CAGR (3Y)
+12.2%
FCF CAGR (5Y)
+10.7%

Quality

14 metrics
Return on equity
16.6%
Return on assets
2.3%
Debt / equity
0.0
Current ratio
1.0
EBITDA (TTM)
$2.75B
Free cash flow (TTM)
$4.33B
Quick ratio
1.0
Interest coverage
—
Net debt / EBITDA
-0.6
Return on invested capital
14.5%
Trailing 12 months
Net cash
$4.54B
Latest balance sheet
Cash & equivalents
$2.20B
Total assets
$192.09B
Total debt
$0

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$4.43B
Capital expenditures (TTM)
$93.70M
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$99.60M
R&D / revenue
—
Stock compensation / revenue
1.4%

Ownership (13F)

9 metrics
13F filers
1,723
13F filer change QoQ
-92
Institutional ownership
90.9%
Conviction holders (share of 13F filers)
1.9%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
-1.6%
Holder tenure
18.0
Price vs estimated holder cost
-16.6%

Ownership (registered funds)

1 metrics
Index-fund ownership
17.6%

Short interest

3 metrics
Short interest
1.5%
Latest settlement · 3.2 days to cover
Days to cover
3.2d
Short-squeeze score
53 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$4.30M
Insider-sentiment score
31 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1156375 CUSIP 12572Q105 13F (30d) 447 filings 430 filers Visit website Investor relations